Trial Profile

Clinical Trial of PfSPZ Vaccine Administered by Direct Venous Inoculation: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naive Adults.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Malaria vaccine live attenuated-Sanaria (Primary)
Indications Falciparum malaria
Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
Sponsors Sanaria

Most Recent Events

12 Sep 2020 Results published in the Clinical Infectious Diseases
13 Dec 2017 Status changed from active, no longer recruiting to completed.
25 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2017.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com